⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28800 | 1.00 | — | — | |
| SCHEMBL3346843 | 0.97 | — | — | |
| SCHEMBL943307 | 0.90 | — | — | |
| SCHEMBL847525 | 0.90 | — | — | |
| SCHEMBL4987 | 0.90 | — | — | |
| SCHEMBL28148497 | 0.88 | — | — | |
| SCHEMBL8997410 | 0.88 | — | — | |
| SCHEMBL27787678 | 0.88 | — | — | |
| Water SCHEMBL28050527 | 0.85 | — | — | |
| SCHEMBL28050663 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346869-A2 | 5-OXAZOLIDIN-2-ONE SUBSTITUTED 1,3,8-TRIAZASPIRO [4.5] DECAN-4-ONE DERIVATIVES USEFUL AS ORL-1 RECEPTOR MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010033451-A2 | 5-OXAZOLIDIN-2-ONE SUBSTITUTED 1,3,8-TRIAZASPIRO [4.5] DECAN-4-ONE DERIVATIVES USEFUL AS ORL-1 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2010-03-25 | — | — | WO | disclosed |